bioAffinity Technologies, Inc.
BIAF
$3.84
-$0.16-3.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.14% | 13.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.14% | 13.91% | |||
| Cost of Revenue | -4.47% | -7.32% | |||
| Gross Profit | 37.47% | 99.25% | |||
| SG&A Expenses | 37.47% | -0.23% | |||
| Depreciation & Amortization | 9.08% | 0.18% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.50% | -1.22% | |||
| Operating Income | -36.82% | 8.86% | |||
| Income Before Tax | 37.91% | -25.20% | |||
| Income Tax Expenses | 0.00% | -88.97% | |||
| Earnings from Continuing Operations | 37.88% | -24.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.88% | -24.39% | |||
| EBIT | -36.82% | 8.86% | |||
| EBITDA | -38.26% | 5.49% | |||
| EPS Basic | 85.18% | 6.60% | |||
| Normalized Basic EPS | 85.19% | 5.99% | |||
| EPS Diluted | 85.18% | 6.60% | |||
| Normalized Diluted EPS | 85.19% | 5.99% | |||
| Average Basic Shares Outstanding | 319.21% | 33.18% | |||
| Average Diluted Shares Outstanding | 319.21% | 33.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||